Prevalence of hypercortisolism in type 2 diabetes patients: A systematic review and meta-Analysis

European Journal of Endocrinology

Volumn 175, Issue 6, 2016, Pages R247-R253

  Steffensen, Charlotte ^a   Pereira, Alberto M ^b   Dekkers, Olaf M ^a,b   Joørgensen, Jens Otto L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX ADENOMA; CONFIDENCE INTERVAL; CUSHING SYNDROME; DIABETIC PATIENT; EMBASE; GLYCEMIC CONTROL; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; IMAGING; LOGISTIC REGRESSION ANALYSIS; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCOPUS; SYSTEMATIC REVIEW; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; META ANALYSIS;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; HUMANS; PREVALENCE;

EID: 85000400720     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0434     Document Type: Review

References (30)

1. World Health Organization. Global Status Report On Noncommunicable Diseases 2014, 2014.
2. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people. Circulation 2008 117 1945-1954. (doi:10.1161/CIRCULATIONAHA.107.720847)
3. Steffensen C, Bak AM, Rubeck KZ & Jørgensen J.O.L. Epidemiology of Cushings syndrome. Neuroendocrinology 2010 92 (Supplement 1) 1-5. (doi:10.1159/000314297)
4. Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen L et al. Incidence and late prognosis of Cushings syndrome: A population-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 117-123.
5. Newell-Price J, Bertagna X, Grossman AB & Nieman LK. Cushings syndrome. Lancet 2006 367 1605-1617. (doi:10.1016/S0140-6736(06)68699-6)
6. Clayton RN, Raskauskiene D, Reulen RC & Jones PW. Mortality and morbidity in Cushings disease over 50 years in stoke-on-Trent, UK: Audit and meta-Analysis of literature. Journal of Clinical Endocrinology and Metabolism 2011 96 632-642. (doi:10.1210/jc.2010-1942)
7. Dekkers OM, Horváth-Puho E, Jørgensen JOL, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM & Sørensen HT. Multisystem morbidity and mortality in cushings syndrome: A cohort study. Journal of Clinical Endocrinology and Metabolism 2013 98 2277-2284. (doi:10.1210/jc.2012-3582)
8. Graversen D, Vestergaard P, Stochholm K, Gravholt CH & Jørgensen JOL. Mortality in Cushings syndrome: A systematic review and meta-Analysis. European Journal of Internal Medicine 2012 23 278-282. (doi:10.1016/j.ejim.2011.10.013)
9. Krarup T, Krarup T & Hagen C. Do patients with type 2 diabetes mellitus have an increased prevalence of Cushings syndrome? Diabetes/Metabolism Research and Reviews 2012 28 219-227. (doi:10.1002/dmrr.2262)
10. Nieman L, Biller B, Findling J, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushings syndrome: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 95 1526-1540. (doi:10.1530/EJE-09-0695)
11. Hamza TH, van Houwelingen HC & Stijnen T. The binomial distribution of meta-Analysis was preferred to model within-study variability. Journal of Clinical Epidemiology 2008 61 41-51. (doi:10.1016/j.jclinepi.2007.03.016)
12. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P & Tabarin A. Occult Cushings syndrome in type-2 diabetes. Journal of Clinical Endocrinology and Metabolism 2003 88 5808-5813. (doi:10.1210/jc.2003-030254)
13. Gagliardi L. Screening for subclinical Cushings syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol. Hormone and Metabolic Research 2010 42 280-284. (doi:10.1055/s-0029-1246191)
14. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E & Gross DJ. Pre-clinical Cushings syndrome: An unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clinical Endocrinology 1996 44 717-722. (doi:10.1046/j.1365-2265.1996.737558.x)
15. Mert M, Temizel M, Erol S, Arman Y, Arslan K, Alakus F & Velioglu EA. Screening for Cushings syndrome in obese type 2 diabetic patients and the predictive factors on the degree of serum cortisol suppression. International Journal of Diabetes in Developing Countries 2012 32 199-202. (doi:10.1007/s13410-012-0091-1)
16. Murakami H, Nigawara T, Sakihara S, Kageyama K, Yamashita M, Matsuki K, Tanabe J, Matsui J, Tamasawa N & Suda T. The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushings disease. Endocrine Journal 2010 57 267-272. (doi:10.1507/endocrj.K09E-352)
17. Newsome S, Chen K, Hoang J, Wilson JD, Potter JM & Hickman PE. Cushings syndrome in a clinic population with diabetes. Internal Medicine Journal 2008 38 178-182. (doi:10.1111/j.1445-5994.2007.01434.x)
18. Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A & Terzolo M. Screening of Cushings syndrome in adult patients with newly diagnosed diabetes mellitus. Clinical Endocrinology 2007 67 225-229. (doi:10.1111/j.1365-2265.2007.02865.x)
19. Taniguchi T, Hamasaki A & Okamoto M. Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus. Endocrine Journal 2008 55 429-432. (doi:10.1507/endocrj.K07E-045)
20. Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M et al. Screening of Cushings syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. Journal of Clinical Endocrinology and Metabolism 2012 97 3467-3475. (doi:10.1210/jc.2012-1323)
21. Caetano M, Silva R & Kater C. Increased diagnostic probability of subclinical Cushings syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus. Arquivos Brasileiros de Endocrinologia & Metabologia 2007 51 1118-1127.
22. Hiroi N, Sue M, Yoshihara A, Ichijo T, Yoshida-Hiroi M, Higa M & Yoshino G. Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus. Diabetology and Metabolic Syndrome 2010 2 71. (doi:10.1186/1758-5996-2-71)
23. Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B & Atkinson AB. Is there value in routine screening for Cushings syndrome in patients with diabetes? Journal of Clinical Endocrinology and Metabolism 2010 95 2262-2265. (doi:10.1210/jc.2009-2453)
24. Liu H, Bravata DM, Cabaccan J, Raff H & Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clinical Endocrinology 2005 63 642-649. (doi:10.1111/j.1365-2265.2005.02395.x)
25. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: A case-control study in hospitalized patients. European Journal of Endocrinology 2005 153 837-844. (doi:10.1530/eje.1.02045)
26. Lindmark S, Burén J & Eriksson JW. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo. Clinical Endocrinology 2006 65 301-309. (doi:10.1111/j.1365-2265.2006.02593.x)
27. Barzon L, Sonino N, Fallo F, Palu G & Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 2003 149 273-285. (doi:10.1530/eje.0.1490273)
28. Donath MY & Shoelson SE. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology 2011 11 98-107. (doi:10.1038/nri2925)
29. Davis SN, Mann S, Briscoe VJ, Ertl AC & Tate DB. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes 2009 58 701-709. (doi:10.2337/db08-1230)
30. Wilson JMG & Jungner G. Principles and Practice of Screening for Disease. Geneva, Switzerland: WHO, 1968.